Jamie Smith
Media Relations
Email: jamie.smith@molnlycke.com
Phone: +46 723 757507
Mölnlycke Health Care unveils new headquarters at GoCo Health Innovation City, marking a new era of collaboration and innovation
Gothenburg, Sweden, 5 March 2025. Mölnlycke Health Care has now established the new headquarters at GoCo Health Innovation City in the Gothenburg region of Sweden. GoCo is a Life Science knowledge hub that brings together companies, scientists, entrepreneurs, health care providers and talent from around the world. The move underscores Mölnlycke's commitment to embracing partnerships and fostering collaboration to drive the health innovations of tomorrow.
“Placing Mölnlycke together with other key players in Life Science is a game-changer. It opens up entirely new possibilities for us to collaborate with experts from various disciplines, and the chance to practice what we preach: embracing partnerships”, says Zlatko Rihter, CEO of Mölnlycke. “Relocating to this new site is a leap forward for Mölnlycke, preparing us for the future with an office designed to meet the new demands of a workplace.”
Investing in a new headquarters as a founding partner at GoCo Health Innovation City provides a unique opportunity to shape and put Gothenburg’s leading MedTech cluster on the map to help revolutionise care. The move reinforces Mölnlycke's strong commitment to Gothenburg, Sweden, and dedication to continue being an attractive employer in the region and beyond.
The state-of-the-art building features significantly improved collaborative spaces, making it easy for everyone to collaborate and socialise with colleagues, customers, and partners. The new headquarters provides three times more capacity for research and development teams compared to before, making room for innovations that can revolutionise care for people and planet.
For more information, please contact:
Latest news
-
5 million and growing: scaling Granudacyn® production in Salzburg
-
First factory in China reaches key milestone and strengthens Mölnlycke’s global manufacturing network
Mölnlycke has completed construction of its first manufacturing facility in China, marking a major milestone in the company's growth journey and strengthening its ability to serve one of the world's largest and fastest growing healthcare markets.
-
Mölnlycke Health Care accelerates U.S. growth journey with three wound care product launches
Peachtree Corners, GA. 7 July, 2026. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, has launched three product innovations in the U.S. since the start of 2026. Designed to expand access to advanced wound care solutions and strengthen the company’s U.S. presence, the portfolio expansion also supports long-term value creation across key market segments.
-
Changes to Mölnlycke Health Care Board of Directors
Gothenburg, Sweden. 23 June 2026. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, today announces changes to its Board of Directors. Christian Cederholm will leave his Board assignment, while Filippa Stenberg will take his place as member of the Board. Thomas Kidane will step in as deputy board member.
-
Mölnlycke Health Care strengthens global manufacturing footprint to power future growth in wound care
Gothenburg, Sweden. 8 June 2026. Mölnlycke Health Care (“Mölnlycke®”), a global leader in MedTech, today confirmed a combined investment of approximately EUR 40 million in Mikkeli, Finland, and Oldham, UK. The investments strengthen the company’s global wound care manufacturing network by increasing capacity, optimising process quality and enhancing supply chain resilience and sustainability.
-
Mölnlycke Health Care and Zhende Medical form pioneering joint venture to expand access to advanced wound care solutions in China
Gothenburg, Sweden, and Shanghai, China. 21 May 2026.
Mölnlycke Health Care (“Mölnlycke®”), a global leader in MedTech and advanced wound care solutions, and Zhende Medical, a leading supplier of medical care and protection in China, today announce the formation of a new joint venture company in China to accelerate growth in one of the world’s fastest-growing wound care markets. The joint venture, majority-owned by Mölnlycke, will integrate the two companies’ wound care portfolios and commercial capabilities to offer healthcare providers, patients and the public expanded access to advanced treatments, improved care delivery and better patient outcomes across China. -
Simple glove change could save the NHS £45 million over five years and improve caesarean safety
Gothenburg, Sweden. 27 April 2026. A new study1 published in the Journal of Hospital Infection shows that introducing a simple glove change during caesarean birth could deliver millions in cost savings for the National Health Service (NHS) in England.
-
Mölnlycke Health Care announces Andreas Johansson as Interim Chief Financial Officer
Gothenburg, Sweden. Wednesday 15 April 2026. Mölnlycke Health Care announces today the appointment of Andreas Johansson as Interim Chief Financial Officer (CFO), with immediate effect.
-
Mölnlycke Health Care annual report 2025 highlights sustainable growth and strategic transformation
Gothenburg, Sweden. 1 April 2026. Today, Mölnlycke Health Care has published its annual report 2025, including sustainability report, outlining the company’s continued focus on revolutionising care for people and planet.